The use of non-routine pleural fluid analysis in the diagnosis of pleural effusion

Respiratory Medicine

Volumn 104, Issue 8, 2010, Pages 1092-1100

  McGrath, Emmet E ^a   Warriner, David ^a   Anderson, Paul B ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Adenosine deaminase; Interferon ; Lipoprotein analysis; Pleural fluid analysis; Triglycerides; Tumour markers

Indexed keywords

ADENOSINE DEAMINASE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMYLASE; ANTINUCLEAR ANTIBODY; BILIRUBIN; C REACTIVE PROTEIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHOLESTEROL; COMPLEMENT; CREATININE; CYTOKERATIN 19 FRAGMENT; GAMMA INTERFERON; GLYCOSAMINOGLYCAN; HYALURONIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESOTHELIN; RHEUMATOID FACTOR; TRIACYLGLYCEROL; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ADENOCARCINOMA; ANALYTIC METHOD; BREAST CARCINOMA; CHYLOTHORAX; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ESOPHAGUS RUPTURE; HEART FAILURE; HEMATOCRIT; HEMATOTHORAX; HUMAN; MALIGNANT MESOTHELIOMA; OVARY CARCINOMA; PANCREATITIS; PLEURA EFFUSION; PLEURA FLUID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADENOSINE DEAMINASE; BIOLOGICAL MARKERS; CHOLESTEROL; DIAGNOSIS, DIFFERENTIAL; EXUDATES AND TRANSUDATES; HUMANS; INTERFERONS; LABORATORY TECHNIQUES AND PROCEDURES; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PLEURAL EFFUSION; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77953912933     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.03.008     Document Type: Review

References (79)

1. Porcel J.M. Tuberculous pleural effusion. Lung (2009)
2. Baba K., Sornes S., Hoosen A.A., Lekabe J.M., Mpe M.J., Langeland N., et al. Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferon-gamma assay. BMC Infect Dis 8 (2008) 35
3. Liang Q.L., Shi H.Z., Wang K., Qin S.M., and Qin X.J. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med 102 5 (2008) 744-754 [4]
4. Lee Y.C., Rogers J.T., Rodriguez R.M., Miller K.D., and Light R.W. Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. Chest 120 2 (2001) 356-361
5. Porcel J.M., and Vives M. Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. Chest 121 4 (2002) 1379-1380
6. Jimenez Castro D., Diaz Nuevo G., Perez-Rodriguez E., and Light R.W. Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions. Eur Respir J 21 2 (2003) 220-224
7. Light R.W. Pleural diseases. 5th ed. (2007), Lippincott Williams & Wilkins, Philadelphia p. 211-24
8. Pérez-Rodriguez E., and Light R.W. Effusions from infections: tuberculosis. In: Light R.W., and Gary Lee Y.C. (Eds). Textbook of pleural diseases. 2nd ed. (2008), Hodder Arnold, London 367-378
9. Zemlin A.E., Burgess L.J., and Carstens M.E. The diagnostic utility of adenosine deaminase isoenzymes in tuberculous pleural effusions. Int J Tuberc Lung Dis 13 2 (2009) 214-220
10. Maskell N.A., and Butland R.J. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 58 Suppl. 2 (2003) ii8-ii17
11. Staats B.A., Ellefson R.D., Budahn L.L., Dines D.E., Prakash U.B., and Offord K. The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 55 11 (1980) 700-704
12. Hamm H., Brohan U., Bohmer R., and Missmahl H.P. Cholesterol in pleural effusions. A diagnostic aid. Chest 92 2 (1987) 296-302
13. Yilmaz A., Tunaboyu I.K., Akkaya E., and Bayramgurler B. A comparative analysis of the biochemical parameters used to distinguish between pleural exudates and transudates. Respirology 5 4 (2000) 363-367
14. Jiang J., Shi H.Z., Liang Q.L., Qin S.M., and Qin X.J. Diagnostic value of interferon-gamma in tuberculous pleurisy: a meta-analysis. Chest 131 4 (2007) 1133-1141
15. Greco S., Girardi E., Masciangelo R., Capoccetta G.B., and Saltini C. Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis 7 8 (2003) 777-786
16. Villena V., Lopez-Encuentra A., Pozo F., Echave-Sustaeta J., Ortuno-de-Solo B., Estenoz-Alfaro J., et al. Interferon gamma levels in pleural fluid for the diagnosis of tuberculosis. Am J Med 115 5 (2003) 365-370
17. Hooper C.E., Lee Y.C., and Maskell N.A. Interferon-gamma release assays for the diagnosis of TB pleural effusions: hype or real hope?. Curr Opin Pulm Med 15 4 (2009) 358-365
18. Ariga H., Kawabe Y., Nagai H., Kurashima A., Masuda K., Matsui H., et al. Diagnosis of active tuberculous serositis by antigen-specific interferon-gamma response of cavity fluid cells. Clin Infect Dis 45 12 (2007) 1559-1567
19. Losi M., Bossink A., Codecasa L., Jafari C., Ernst M., Thijsen S., et al. Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. Eur Respir J 30 6 (2007) 1173-1179
20. Marel M., Zrustova M., Stasny B., and Light R.W. The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia. Chest 104 5 (1993) 1486-1489
21. Bartter T., Santarelli R., Akers S.M., and Pratter M.R. The evaluation of pleural effusion. Chest 106 4 (1994) 1209-1214
22. McCullough P.A., Omland T., and Maisel A.S. B-type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med 4 2 (2003) 72-80
23. Liao H., Na M.J., Dikensoy O., Lane K.B., Randal B., and Light R.W. Diagnostic value of pleural fluid N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases. Respirology 13 1 (2008) 53-57
24. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 3 (2002) 161-167
25. Seyhan E.C., Altin S., Cetinkaya E., Sokucu S., Gunluoglu M.Z., Demir A., et al. The importance of pleural fluid and serum NT-proBNP levels in differentiating pleural effusion due to heart failure from other causes of effusion. Intern Med 48 5 (2009) 287-293
26. Kolditz M., Halank M., Schiemanck C.S., Schmeisser A., and Hoffken G. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. Eur Respir J 28 1 (2006) 144-150
27. Porcel J.M., Martinez-Alonso M., Cao G., Bielsa S., Sopena A., and Esquerda A. Biomarkers of heart failure in pleural fluid. Chest 136 3 (2009 Sep) 671-677
28. Roth B.J., O'Meara T.F., and Cragun W.H. The serum-effusion albumin gradient in the evaluation of pleural effusions. Chest 98 3 (1990) 546-549
29. Han C.H., Choi J.E., and Chung J.H. Clinical utility of pleural fluid NT-pro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions. Intern Med 47 19 (2008) 1669-1674
30. Ferrer J., Villarino M.A., Encabo G., Felip E., Bermejo B., Vila S., et al. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Cancer 86 8 (1999) 1488-1495
31. Bielsa S., Esquerda A., Salud A., Montes A., Arellano E., Rodriguez-Panadero F., et al. High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions. Eur J Intern Med 20 4 (2009) 383-386
32. Perkins G.L., Slater E.D., Sanders G.K., and Prichard J.G. Serum tumor markers. Am Fam Physician 68 6 (2003) 1075-1082
33. Tomita M., Shimizu T., Matsuzaki Y., Hara M., Ayabe T., and Onitsuka T. Prognostic significance of carcinoembryonic antigen level in pleural lavage fluid for patients with lung adenocarcinoma. Ann Thorac Surg 80 1 (2005) 276-281
34. Galbis Caravajal J.M., Benlloch Carrion S., Sanchez Paya J., Mafe Madueno J.J., Baschwitz Gomez B., and Rodriguez Paniagua J.M. Prognostic value of the carcinoembryonic antigen found in pleural lavage fluid from patients with lung carcinoma. Arch Bronconeumol 41 4 (2005) 185-188
35. Nicolini A., Tartarelli G., Carpi A., Metelli M.R., Ferrari P., Anselmi L., et al. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases. BMC Cancer 6 (2006) 269
36. Ghayumi S.M., Mehrabi S., Doroudchi M., and Ghaderi A. Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients. Pathol Oncol Res 11 4 (2005) 236-241
37. Wagner I.C., Guimaraes M.J., da Silva L.K., de Melo F.M., and Muniz M.T. Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion. J Bras Pneumol 33 2 (2007) 185-191
38. Li C.S., Cheng B.C., Ge W., and Gao J.F. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions. Int J Clin Pract 61 3 (2007) 444-448
39. Chang K., and Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci U S A 93 1 (1996 Jan 9) 136-140
40. Robinson B.W., Creaney J., Lake R., Nowak A., Musk A.W., de Klerk N., et al. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 362 9396 (2003 Nov 15) 1612-1616
41. Scherpereel A., Grigoriu B., Conti M., Gey T., Grégoire M., Copin M.C., et al. Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma. Am J Respir Crit Care Med 173 10 (2006 May 15) 1155-1160
42. Creaney J., Yeoman D., Naumoff L.K., Hof M., Segal A., Musk A.W., et al. Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma. Thorax 62 7 (2007 Jul) 569-576
43. Robinson B.W., and Lake R.A. Advances in malignant mesothelioma. N Engl J Med 353 (2005) 1591-1603
44. Light R.W. Tumor markers in undiagnosed pleural effusions. Chest 126 6 (2004) 1721-1722
45. Porcel J.M., Vives M., Esquerda A., Salud A., Perez B., and Rodriguez-Panadero F. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 126 6 (2004) 1757-1763
46. Sahn S.A. State of the art. The pleura. Am Rev Respir Dis 138 1 (1988) 184-234 [54]
47. Villena V., Perez V., Pozo F., Lopez-Encuentra A., Echave-Sustaeta J., Arenas J., et al. Amylase levels in pleural effusions: a consecutive unselected series of 841 patients. Chest 121 2 (2002) 470-474
48. Foresti V., Villa A., and Zubani R. Amylase concentrations in pleural effusions. Chest 105 5 (1994) 1625-1626
49. Ende N. Studies of amylase activity in pleural effusions and ascites. Cancer 13 (1960) 283-287
50. Branca P., Rodriguez R.M., Rogers J.T., Ayo D.S., Moyers J.P., and Light R.W. Routine measurement of pleural fluid amylase is not indicated. Arch Intern Med 161 2 (2001) 228-232
51. Sherr H.P., Light R.W., Merson M.H., Wolf R.O., Taylor L.L., and Hendrix T.R. Origin of pleural fluid amylase in esophageal rupture. Ann Intern Med 76 6 (1972) 985-986
52. Kramer M.R., Saldana M.J., Cepero R.J., and Pitchenik A.E. High amylase levels in neoplasm-related pleural effusion. Ann Intern Med 110 7 (1989) 567-569
53. Walport M.J. Complement. Second of two parts. N Engl J Med 344 15 (2001) 1140-1144
54. Hara N., Abe M., Inuzuka S., Kawarada Y., and Shigematsu N. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions. Chest 102 4 (1992) 1060-1064
55. Halla J.T., Schrohenloher R.E., and Volanakis J.E. Immune complexes and other laboratory features of pleural effusions: a comparison of rheumatoid arthritis, systemic lupus erythematosus, and other diseases. Ann Intern Med 92 6 (1980) 748-752
56. Salomaa E.R., Viander M., Saaresranta T., and Terho E.O. Complement components and their activation products in pleural fluid. Chest 114 3 (1998) 723-730
57. Hidaka K., Abe M., Tanaka T., Mitsuyama T., Hara N., and Hara N. Comparison of complement activation between tuberculous and malignant pleuritis. Nihon Kyobu Shikkan Gakkai Zasshi 33 4 (1995) 379-383
58. Porcel J.M., Vives M., Gazquez I., Vicente de Vera M.C., Perez B., and Rubio M. Usefulness of pleural complement activation products in differentiating tuberculosis and malignant effusions. Int J Tuberc Lung Dis 4 1 (2000) 76-82
59. Shitrit D., Ollech J.E., Ollech A., Peled N., Amital A., Fox B., et al. Diagnostic value of complement components in pleural fluid: report of 135 cases. Respir Med 102 11 (2008) 1631-1635
60. Joseph J., and Sahn S.A. Connective tissue diseases and the pleura. Chest 104 1 (1993) 262-270
61. Porcel J.M., Ordi-Ros J., Esquerda A., Vives M., Madronero A.B., Bielsa S., et al. Antinuclear antibody testing in pleural fluid for the diagnosis of lupus pleuritis. Lupus 16 1 (2007) 25-27
62. Wang D.Y., Yang P.C., Yu W.L., Kuo S.H., and Hsu N.Y. Serial antinuclear antibodies titre in pleural and pericardial fluid. Eur Respir J 15 6 (2000) 1106-1110
63. Faurschou P. Decreased glucose in RA-cell-positive pleural effusion: correlation of pleural glucose, lactic dehydrogenase and protein concentration to the presence of RA-cells. Eur J Respir Dis 65 4 (1984) 272-277
64. Balbir-Gurman A., Yigla M., Nahir A.M., and Braun-Moscovici Y. Rheumatoid pleural effusion. Semin Arthritis Rheum 35 6 (2006) 368-378
65. Berkman N., Liss H., and Kramer M.R. Pyelonephritis as a cause of pleural effusion. Respiration 63 6 (1996) 384-386
66. Falguera M., Lopez A., Nogues A., Porcel J.M., and Rubio-Caballero M. Evaluation of the polymerase chain reaction method for detection of Streptococcus pneumoniae DNA in pleural fluid samples. Chest 122 6 (2002) 2212-2216
67. Pai M., Flores L.L., Hubbard A., Riley L.W., and Colford Jr. J.M. Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis. BMC Infect Dis 4 (2004) 6
68. Ilonidis G., Parapanisiou E., Anogeianaki A., Giavazis I., Theofilogiannakos E.K., Tsekoura P., et al. Interleukin-1beta (IL-1 beta), interleukin 6 (IL-6) and tumor necrosis factor (TNF) in plasma and pleural fluid of pneumonia, lung cancer and tuberculous pleuritis. J Biol Regul Homeost Agents 20 1-2 (2006) 41-46
69. Alexandrakis M.G., Kyriakou D., Alexandraki R., Pappa K.A., Antonakis N., and Bouros D. Pleural interleukin-1 beta in differentiating transudates and exudates: comparative analysis with other biochemical parameters. Respiration 69 3 (2002) 201-206
70. Kiropoulos T.S., Kostikas K., Oikonomidi S., Tsilioni I., Nikoulis D., Germenis A., et al. Acute phase markers for the differentiation of infectious and malignant pleural effusions. Respir Med 101 5 (2007) 910-918
71. Xirouchaki N., Tzanakis N., Bouros D., Kyriakou D., Karkavitsas N., Alexandrakis M., et al. Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions. Chest 121 3 (2002) 815-820
72. Lin F.C., Chen Y.C., Chen F.J., and Chang S.C. Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions. Clin Immunol 116 2 (2005) 166-173
73. Aleman C., Alegre J., Monasterio J., Segura R.M., Armadans L., Angles A., et al. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Clin Sci (Lond) 105 5 (2003) 601-607
74. Porcel J.M., Galindo C., Esquerda A., Trujillano J., Ruiz-Gonzalez A., Falguera M., et al. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions. Respirology 13 1 (2008) 58-62
75. Porcel J.M., Vives M., Cao G., Bielsa S., Ruiz-González A., Martínez-Iribarren A., et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J 34 6 (2009 Dec) 1383-1389
76. Porcel J.M., Ruiz-Gonzalez A., Falguera M., Nogues A., Galindo C., Carratala J., et al. Contribution of a pleural antigen assay (Binax NOW) to the diagnosis of pneumococcal pneumonia. Chest 131 5 (2007) 1442-1447
77. Budak F., Uzaslan E.K., Cangur S., Goral G., and Oral H.B. Increased pleural soluble fas ligand (sFasL) levels in tuberculosis pleurisy and its relation with T-helper type 1 cytokines. Lung 186 5 (2008) 337-343
78. Vavetsi R., Bonovas S., Polizou P., Papanastasopoulou C., Dougekou G., and Sitaras N.M. The diagnostic role of glycosaminoglycans in pleural effusions: a pilot study. BMC Pulm Med 9 (2009) 9
79. Soderblom T., Pettersson T., Nyberg P., Teppo A.M., Linko L., and Riska H. High pleural fluid hyaluronan concentrations in rheumatoid arthritis. Eur Respir J 13 3 (1999) 519-522